Skip to main content
Log in

Disordered Gambling in Adolescents

Epidemiology, Diagnosis, and Treatment

  • Therapy In Practice
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Rapid expansion of legalized gambling has been associated with increased rates of gambling disorders among adults and adolescents worldwide. Epidemiologic studies suggest that, in North America, up to 6% of adults and 20% of adolescents have a gambling problem. Despite increasing prevalence rates of gambling disorders, little research is available on how to treat such disorders in adolescents. Much of what is known about how to treat adolescent problem and pathological gambling comes from research on psychosocial and psychopharmacologic treatments for adult pathological gambling.

Risk factors for adolescent gambling disorders include male gender, alcohol and drug use, deviant peers, family history of gambling, and impulsive behavior. While several risk factors characterize disordered gambling among adolescents, the extent to which these characteristics are related remains to be determined. In terms of screening for adolescent problem and pathological gambling, several instruments designed to reflect the Diagnostic and Statistical Manual of Mental Disorders diagnostic criteria for pathological gambling are available.

Psychosocial approaches used to treat adult pathological gambling include Gamblers Anonymous, cognitive-behavioral therapy (CBT), and motivational enhancement therapy (MET). Among adolescents, CBT as well as an eclectic therapy have been helpful in reducing problematic gambling behavior. In terms of pharmacotherapy, three classes of psychotropic drugs have been used to treat adult pathological gambling — serotonin reuptake inhibitors, opioid antagonists, and mood stabilizers. While some of these pharmacotherapies have been efficacious in treating adult pathological gambling, additional double-blind, placebo-controlled studies are needed to determine the long-term effectiveness of these treatments. No known study has evaluated the use of psychopharmacologic agents in treating adolescent pathological gambling.

Possible reasons for the lack of research on treatment for adolescent gambling disorders include lack of motivation to pursue treatment, feelings of self-control, and negative perception of therapy. Referrals from parents, teachers, and peers of adolescents, as well as community outreach programs, may be useful in successfully deriving a treatment population. Clinicians are advised to be sensitive to behavioral risk factors and to screen for disordered gambling in high risk adolescents. A combination of CBT and MET, as well as medication for any comorbid psychiatric condition, is recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

Similar content being viewed by others

References

  1. National Gambling Impact Study Commission. Final report. Washington, DC: Government Printing Office, 1999

    Google Scholar 

  2. National Research Council. Pathological gambling: a critical review. Washington, DC: National Academy Press, 1999

    Google Scholar 

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 2000

    Google Scholar 

  4. Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 1999; 89: 1369–76

    Article  PubMed  CAS  Google Scholar 

  5. Stinchfield R. Youth gambling: how big a problem? Psychiatr Ann 2002; 32: 197–202

    Google Scholar 

  6. Weite J, Barnes G, Wieczorek W. Alcohol and gambling pathology among US adults: prevalence, demographic patterns and comorbidity. J Stud Alcohol 2001; 62: 706–12

    Google Scholar 

  7. Bergh C, Kuhlhorn E. Social, psychological and physical consequences of pathological gambling in Sweden. J Gambl Stud 1994; 10: 275–85

    Article  Google Scholar 

  8. Cunningham-Williams RM, Cottier LB, Compton WM, et al. Taking chances: problem gamblers and mental health disorders: results from the St Louis Epidemiologic Catchment Area study. Am J Public Health 1998; 88: 1093–6

    Article  PubMed  CAS  Google Scholar 

  9. Daghestani AN. Impotence associated with compulsive gambling. J Clin Psychiatry 1987; 48: 115–6

    PubMed  CAS  Google Scholar 

  10. Lesieur HR, Blume SB, Zoppa R. Alcoholism, drug abuse and gambling. Alcohol Clin Exp Res 1986; 10: 33–8

    Article  PubMed  CAS  Google Scholar 

  11. Miller MM. Medical approaches to gambling issues (I): the medical condition. Wis Med J 1996; 95: 623–34

    PubMed  CAS  Google Scholar 

  12. Sommers I. Pathological gambling: estimating prevalence and group characteristics. Int J Addict 1988; 23: 477–90

    PubMed  CAS  Google Scholar 

  13. McCormick RA, Russo AM, Ramirez LF, et al. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 1984; 141: 215–8

    PubMed  CAS  Google Scholar 

  14. Ladouceur R, Dube D, Bujold A. Prevalence of pathological gamblers and related problems among college students in the Quebec metropolitan area. Can J Psychiatry 1994; 39: 289–93

    PubMed  CAS  Google Scholar 

  15. Petry NM, Kiluk BD. Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. J Nerv Ment Dis 2002; 190: 462–9

    Article  PubMed  Google Scholar 

  16. Jacobs DF. Juvenile gambling in North America: an analysis of long term trends and future prospects. J Gambl Stud 2000; 16: 119–52

    Article  PubMed  CAS  Google Scholar 

  17. Westphal JR, Rush JA, Stevens L, et al. Gambling behavior of Louisiana students in grades 6 through 12. Psychiatr Serv 2000; 51: 96–9

    PubMed  CAS  Google Scholar 

  18. Stinchfield R, Winters KC. Gambling and problem gambling among youth. Ann Am Acad Pol Soc Sci 1998; 556: 172–85

    Article  Google Scholar 

  19. Stinchfield R. Gambling and correlates of gambling among Minnesota public school students. J Gambl Stud 2000; 16: 153–73

    Article  PubMed  CAS  Google Scholar 

  20. Volberg R. Gambling and problem gambling among adolescents in New York. Albany (NY): New York Council on Problem Gambling, 1988

    Google Scholar 

  21. Winters KC, Stinchfield R, Botzet A, et al. A prospective study of youth gambling behaviors. Psychol Addict Behav 2002; 16: 3–9

    Article  PubMed  Google Scholar 

  22. Griffiths M, Sutherland I. Adolescent gambling and drug use. J Community Appl Soc Psychol 1998; 8: 423–7

    Article  Google Scholar 

  23. Stinchfield R, Cassuto N, Winters K, et al. Prevalence of gambling among Minnesota public school students in 1992 and 1995. J Gambl Stud 1997; 13: 25–48

    Article  PubMed  CAS  Google Scholar 

  24. Vitaro F, Ferland F, Jacques C, et al. Gambling, substance use, and impulsivity during adolescence. Psychol Addict Behav 1998; 12: 185–94

    Article  Google Scholar 

  25. Petry NM, Tawfik Z. Comparison of problem-gambling and non-problem-gambling youths seeking treatment for marijuana abuse. J Am Acad Child Adolesc Psychiatry 2001; 40: 1324–31

    Article  PubMed  CAS  Google Scholar 

  26. Barnes GM, Weite JW, Hoffman JH, et al. Gambling and alcohol use among youth: influences of demographic, socialization, and individual factors. Addict Behav 1999; 24: 749–67

    Article  PubMed  CAS  Google Scholar 

  27. Gupta R, Derevensky JL. Familial and social influences on juvenile gambling. J Gambl Stud 1997; 13: 179–92

    Article  PubMed  CAS  Google Scholar 

  28. Browne BA, Brown DJ. Predictors of lottery gambling among American college students. J Soc Psychol 1994; 134: 339–47

    Article  PubMed  CAS  Google Scholar 

  29. Lesieur HR, Klein R. Pathological gambling among high school students. Addict Behav 1987; 12: 129–35

    Article  PubMed  CAS  Google Scholar 

  30. Vitaro F, Arseneault L, Tremblay RE. Dispositional predictors of problem gambling in male adolescents. Am J Psychiatry 1997; 154: 1769–70

    PubMed  CAS  Google Scholar 

  31. Vitaro F, Arseneault L, Tremblay RE. Impulsivity predicts problem gambling in low SES adolescent males. Addiction 1999; 94: 565–75

    Article  PubMed  CAS  Google Scholar 

  32. Winters KC, Stinchfield R, Fulkerson J. Toward the development of an adolescent gambling problem severity scale. J Gambl Stud 1993; 9: 371–86

    Article  Google Scholar 

  33. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987; 144: 1184–8

    PubMed  CAS  Google Scholar 

  34. Ferris J, Wynne H, Single E. Measuring problem gambling in Canada: final report-phase I. Ottawa (ON): Inter-Provincial Task Force on Problem Gambling, 1999

    Google Scholar 

  35. Fisher S. Measuring pathological gambling in children: the case of fruit machines in the UK. J Gambl Stud 1992; 8: 263–85

    Article  Google Scholar 

  36. Derevensky JL, Gupta R. Prevalence estimates of adolescent gambling: a comparison of the SOGS-RA, DSM-IV-J, and the GA 20 questions. J Gambl Stud 2000; 16: 227–51

    Article  PubMed  CAS  Google Scholar 

  37. Fisher S. Developing the DSM-IV criteria to identify adolescent problem gambling in non-clinical populations. J Gambl Stud 2000; 16: 253–73

    Article  PubMed  CAS  Google Scholar 

  38. Shaffer HJ, LaBrie R, Scanlan KM, et al. Pathological gambling among adolescents: Massachusetts Gambling Screen (MAGS). J Gambl Stud 1994; 10: 339–62

    Article  Google Scholar 

  39. Gamblers Anonymous International Service Office. 20 questions [online]. Available from URL: http://www.gamblersanonymous.org/20questions.html/ [Accessed 2003 Feb 27]

  40. Petry NM, Armentano C. Prevalence, assessment and treatment of pathological gambling: a review. Psychiatr Serv 1999; 50: 1021–7

    PubMed  CAS  Google Scholar 

  41. Stewart RM, Brown RIF. An outcome study of Gamblers Anonymous. Br J Psychiatry 1988; 152: 284–8

    Article  PubMed  CAS  Google Scholar 

  42. Lesieur HR, Blume SB. Evaluation of patients treated for pathological gambling in a combined alcohol, substance abuse, and pathological gambling treatment unit using the addiction severity index. Br J Addict 1991; 86: 1017–28

    Article  PubMed  CAS  Google Scholar 

  43. Russo AM, Taber JI, McCormick RA, et al. An outcome study of an inpatient treatment program for pathological gamblers. Hosp Community Psychiatry 1984; 35: 823–7

    PubMed  CAS  Google Scholar 

  44. Taber JI, McCormick RA, Ramirez LF. The prevalence and impact of major life Stressors among pathological gamblers. Int J Addict 1987; 22: 71–9

    PubMed  CAS  Google Scholar 

  45. Petry NM. Patterns and correlates of Gamblers Anonymous attendance in pathological gamblers seeking professional treatment. Addict Behav 2003; 28: 1049–62

    Article  PubMed  Google Scholar 

  46. Gaboury A, Ladouceur R. Erroneous perceptions and gambling. J Soc Behav Pers 1989; 4: 411–20

    Google Scholar 

  47. Sylvain C, Ladouceur R, Boisvert JM. Cognitive and behavioral treatment of pathological gambling: a controlled study. J Consult Clin Psychol 1997; 65: 727–32

    Article  PubMed  CAS  Google Scholar 

  48. Ladouceur R, Sylvain C, Boutin C, et al. Cognitive treatment of pathological gambling. J Nerv Ment Dis 2001; 189: 774–80

    Article  PubMed  CAS  Google Scholar 

  49. Ladouceur R, Boisvert JM, Dumont J. Cognitive-behavioral treatment for adolescent pathological gamblers. Behav Modif 1994; 18: 230–42

    Article  PubMed  CAS  Google Scholar 

  50. Gupta R, Derevensky JL. Adolescents with gambling problems: from research to treatment. J Gambl Stud 2000; 16: 315–42

    Article  PubMed  CAS  Google Scholar 

  51. Miller WR, Brown JM, Simpson TL, et al. A methodological analysis of the alcohol treatment outcome literature. In: Hester RK, Miller WR, editors. Handbook of alcoholism treatment approaches. Boston (MA): Allyn & Bacon, 1995: 12–44

    Google Scholar 

  52. Hodgins DC, Currie SR, el-Guebaly N. Motivational enhancement and self-help treatments for problem gambling. J Consult Clin Psychol 2001; 69: 50–7

    Article  PubMed  CAS  Google Scholar 

  53. Sampl S, Kadden R. Motivational enhancement therapy and cognitive behavioral therapy for adolescent cannabis users: 5 sessions. Cannabis Youth Treatment (CYT) Series. Vol. 1. Rockville (MD): Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 2001

    Google Scholar 

  54. Hollander E, Frenkel M, DeCaria C, et al. Treatment of pathological gambling with clomipramine. Am J Psychiatry 1992; 149: 710–1

    PubMed  CAS  Google Scholar 

  55. Sallee FR, Vrindavanam NS, Deas-Nesmith D, et al. Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. Am J Psychiatry 1997; 154: 668–7

    PubMed  CAS  Google Scholar 

  56. Remington G, Sloman L, Konstantareas M, et al. Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study. J Clin Psychopharmacol 2001; 21: 440–4

    Article  PubMed  CAS  Google Scholar 

  57. Figueroa Y, Rosenberg DR, Birmaher B, et al. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol 1998; 8: 61–7

    Article  PubMed  CAS  Google Scholar 

  58. Hollander E, DeCaria C, Mari E, et al. Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 1998; 155: 1781–3

    PubMed  CAS  Google Scholar 

  59. Hollander E, DeCaria CM, Finkell JN, et al. A randomized double-blind fluvox-amine/placebo crossover trial in pathologic gambling. Biol Psychiatry 2000; 47: 813–7

    Article  PubMed  CAS  Google Scholar 

  60. Blanco C, Petkova E, Ibanez A, et al. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002; 14: 9–15

    PubMed  Google Scholar 

  61. Cheer SM, Figgitt DP. Spotlight on fluvoxamine in anxiety disorders in children and adolescents. CNS Drugs 2002; 16: 139–44

    Article  PubMed  Google Scholar 

  62. Strauss WL, Unis AS, Cowan C, et al. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders. Am J Psychiatry 2002; 159: 755–60

    Article  PubMed  Google Scholar 

  63. Zimmerman M, Breen RB, Posternak MA. An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry 2002; 63: 44–8

    Article  PubMed  CAS  Google Scholar 

  64. Armenteros JL, Lewis JE. Citalopram treatment for impulsive aggression in children and adolescents: an open pilot study. J Am Acad Child Adolesc Psychiatry 2002; 41: 522–9

    Article  PubMed  Google Scholar 

  65. Seedat S, Stein DJ, Ziervogel C, et al. Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with post-traumatic stress disorder. J Child Adolesc Psychopharmacol 2002; 12: 37–46

    Article  PubMed  Google Scholar 

  66. Thomsen PH, Ebbesen C, Persson C. Long-term experience with citalopram in the treatment of adolescent OCD. J Am Acad Child Adolesc Psychiatry 2001; 40: 895–902

    Article  PubMed  CAS  Google Scholar 

  67. Bostic JQ, Prince J, Brown K, et al. A retrospective study of citalopram in adolescents with depression. J Child Adolesc Psychopharmacol 2001; 11: 159–66

    Article  PubMed  CAS  Google Scholar 

  68. Kim SW, Grant JE, Adson DE, et al. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002; 63: 501–7

    Article  PubMed  CAS  Google Scholar 

  69. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001; 40: 762–72

    Article  PubMed  CAS  Google Scholar 

  70. Rosenberg DR, Stewart CM, Fitzgerald KD, et al. Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1999; 38: 1180–5

    Article  PubMed  CAS  Google Scholar 

  71. de la Gandara JJ. Fluoxetine: open-trial in pathological gambling. 152nd Annual Meeting of the American Psychiatric Association; 1999 May 16–21; Washington, DC

  72. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54: 1031–7

    Article  PubMed  CAS  Google Scholar 

  73. Geller DA, Hoog SL, Heiligenstein JH, et al. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 2001; 40: 773–9

    Article  PubMed  CAS  Google Scholar 

  74. Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994; 33: 1000–6

    Article  PubMed  CAS  Google Scholar 

  75. Grant JE, Kim SW. Pharmacotherapy of pathological gambling. Psychiatr Ann 2002; 32: 186–91

    Google Scholar 

  76. Kim SW, Grant JE, Adson DE, et al. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49: 914–21

    Article  PubMed  CAS  Google Scholar 

  77. Crockford DN, el-Guebaly N. Naltrexone in the treatment of pathological gambling and alcohol dependence [letter]. Can J Psychiatry 1998; 43: 86

    PubMed  CAS  Google Scholar 

  78. Campbell M, Anderson LT, Small AM, et al. Naltrexone in autistic children: a double-blind and placebo-controlled study. Psychopharmacol Bull 1990; 26: 130–5

    PubMed  CAS  Google Scholar 

  79. Wold M, Kaminer Y. Naltrexone for alcohol abuse. J Am Acad Child Adolesc Psychiatry 1997; 36: 6–7

    Article  PubMed  CAS  Google Scholar 

  80. Chabane N, Leboyer M, Mouren-Simeoni MC. Opiate antagonists in children and adolescents. Eur Child Adolesc Psychiatry 2000; 9Suppl. 1: 144–50

    Google Scholar 

  81. Moskowitz JA. Lithium and lady luck: use of lithium carbonate in compulsive gambling. NY State J Med 1980; 80: 785–8

    CAS  Google Scholar 

  82. Pallanti S, Quercioli L, Sood E, et al. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry 2002; 63: 559–64

    Article  PubMed  CAS  Google Scholar 

  83. Haller R, Hinterhuber H. Treatment of pathological gambling with carbamazepine [letter]. Pharmacopsychiatry 1994; 27: 129

    Article  PubMed  CAS  Google Scholar 

  84. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000; 39: 713–20

    Article  PubMed  CAS  Google Scholar 

  85. Donovan SJ, Stewart JW, Nunes EV, et al. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry 2000; 157: 818–20

    Article  PubMed  CAS  Google Scholar 

  86. Ryan ND, Bhatara VS, Perel JM. Mood stabilizers in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38: 529–36

    Article  PubMed  CAS  Google Scholar 

  87. McElroy SL, Pope HG, Keck PE, et al. Are impulse-control disorders related to bipolar disorder? Compr Psychiatry 1996; 37: 229–40

    Article  PubMed  CAS  Google Scholar 

  88. Hardoon K, Derevensky J, Gupta R. Empirical measures vs perceived gambling severity: why adolescents don’t present themselves for treatment. Addict Behav 2003; 28: 933–46

    Article  PubMed  Google Scholar 

  89. Crockford DN, el-Guebaly N. Psychiatric comorbidity in pathological gambling: a critical review. Can J Psychiatry 1998; 43: 43–50

    PubMed  CAS  Google Scholar 

  90. Kim SW, Grant JE, Grosz RL. Pathological gambling: current status and new treatments. Minn Med 2002; 85: 48–52

    PubMed  Google Scholar 

  91. Grant JE, Kim SW. Effectiveness of pharmacotherapy for pathological gambling: a chart review. Ann Clin Psychiatry 2002; 14: 155–61

    PubMed  Google Scholar 

  92. Petry NM. How treatments for pathological gambling can be informed by treatments for substance use disorders. Exp Clin Psychopharmacol 2002; 10: 184–92

    Article  PubMed  Google Scholar 

  93. American Gaming Association. Responsible gaming resource guide. 2nd ed. Washington, DC: American Gaming Association, 1998

    Google Scholar 

  94. Gaboury A, Ladouceur R. Evaluation of a prevention program for pathological gambling among adolescents. J Prim Prev 1993; 14: 21–8

    Article  Google Scholar 

  95. Dickson LM, Derevensky JL, Gupta R. The prevention of gambling problems in youth: a conceptual framework. J Gambl Stud 2002; 18: 97–159

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Preparation of this report was supported in part by NIH grants R01-MH60417, R01-MH60417-Supp, R01-DA13444, R01-DA14618, R29-DA12056, P50-AA03510, P50-DA09241, and the Patrick and Catherine Weldon Donaghue Medical Research Foundation Investigator Program. The authors do not have any potential conflicts of interest directly relevant to the contents of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nancy M. Petry.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pietrzak, R.H., Ladd, G.T. & Petry, N.M. Disordered Gambling in Adolescents. Pediatr-Drugs 5, 583–595 (2003). https://doi.org/10.2165/00148581-200305090-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00148581-200305090-00002

Keywords

Navigation